Drug Profile
Indecainide - Eli Lilly and Company
Alternative Names: Decabid; LY 135837; RicainideLatest Information Update: 07 Jul 1995
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class Antiarrhythmics; Class Ic antiarrhythmics; Fluorenes; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Ventricular arrhythmias
- Discontinued Arrhythmias
Most Recent Events
- 17 May 1995 Discontinued-II for Arrhythmias in United Kingdom (IV)
- 17 May 1995 Discontinued-II for Arrhythmias in United Kingdom (PO)
- 17 May 1995 Discontinued-II for Ventricular arrhythmias in United Kingdom (IV)